Zhejiang Hisun Biomaterials Stock Working Capital
| 688203 Stock | 10.49 0.21 2.04% |
Zhejiang HISUN Biomaterials fundamentals help investors to digest information that contributes to Zhejiang HISUN's financial success or failures. It also enables traders to predict the movement of Zhejiang Stock. The fundamental analysis module provides a way to measure Zhejiang HISUN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhejiang HISUN stock.
The current year's Change In Working Capital is expected to grow to about 60.2 M, whereas Net Working Capital is forecasted to decline to about 496.4 M. Zhejiang | Working Capital |
Zhejiang HISUN Biomaterials Company Working Capital Analysis
Zhejiang HISUN's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Zhejiang HISUN Working Capital | 627.83 M |
Most of Zhejiang HISUN's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhejiang HISUN Biomaterials is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Zhejiang Capital Lease Obligations
Capital Lease Obligations |
|
In accordance with the company's disclosures, Zhejiang HISUN Biomaterials has a Working Capital of 627.83 M. This is 12.32% lower than that of the Chemicals sector and 65.7% lower than that of the Materials industry. The working capital for all China stocks is 57.53% higher than that of the company.
Zhejiang Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhejiang HISUN's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhejiang HISUN could also be used in its relative valuation, which is a method of valuing Zhejiang HISUN by comparing valuation metrics of similar companies.Zhejiang HISUN is currently under evaluation in working capital category among its peers.
Zhejiang Fundamentals
| Return On Equity | 0.0267 | ||||
| Return On Asset | 0.012 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.76 B | ||||
| Shares Outstanding | 202.68 M | ||||
| Shares Owned By Insiders | 70.21 % | ||||
| Shares Owned By Institutions | 1.15 % | ||||
| Price To Book | 1.39 X | ||||
| Price To Sales | 2.46 X | ||||
| Revenue | 753.32 M | ||||
| Gross Profit | 80.89 M | ||||
| EBITDA | 100.72 M | ||||
| Net Income | 43.55 M | ||||
| Total Debt | 179.55 M | ||||
| Book Value Per Share | 7.39 X | ||||
| Cash Flow From Operations | 163.03 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Number Of Employees | 383 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 2.13 B | ||||
| Total Asset | 2.05 B | ||||
| Retained Earnings | 65.57 M | ||||
| Working Capital | 627.83 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.05 B | ||||
| Last Dividend Paid | 0.08 |
About Zhejiang HISUN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang HISUN Biomaterials's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang HISUN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang HISUN Biomaterials based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Zhejiang Stock
Zhejiang HISUN financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang HISUN security.